Last reviewed · How we verify
NCT06828432: CRUISE
CTICU Device Study CRUISE
trial testing CRUISE CTICU CareTaker Vitalstream Device in Open Heart Surgery in 50 participants. Enrolling by invitation.
31 January 2027
Quick facts
| Lead sponsor | Hernando Gomez |
|---|---|
| Status | ENROLLING BY INVITATION |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 3 June 2025 |
| Primary completion | 31 January 2027 |
| Estimated completion | 31 January 2027 |
| Sites | 1 location across United States |
Drugs / interventions tested
- CRUISE CTICU CareTaker Vitalstream Device
- CRUISE CTICU CNAP Device
- CRUISE CTICU Edwards Clearsight Device
Conditions studied
- Open Heart Surgery — all drugs for Open Heart Surgery →
Sponsor
Hernando Gomez — full company profile →
Who can join
Adults 18 to 105, any sex, with Open Heart Surgery. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this study evaluate three novel, Food and Drug Administration (FDA)-approved devices currently used to monitor blood pressure and the amount of blood that the heart pumps during each beat. These devices are the ClearSight (Edwards Life Sciences), CareTaker (CareTaker Medical) and CNAP (CNS Systems). These devices measure blood pressure, how much blood the heart is pumping around the body each minute and on a heartbeat to heartbeat basis and other parameters that can tell the doctor if the patient will benefit from specific treatments. The purpose of this study is to determine the accuracy of these devices. This knowledge will help us understand how investigators can use such non-invasive devices to care for patients at less risk than the devices currently used for such purposes. The main question the study aims to answer is: • What monitor is the most accurate in capturing non-invasive patient data?
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06828432
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Open Heart Surgery
Currently open trials in the same condition.
- NCT06833320 — Propranolol Treatment for Postoperative Chylothorax · Phase 1, PHASE2 · recruiting
- NCT07257744 — Comparison of IV Analgesia, Thoracic Epidural Analgesia, and ESP Block for Chronic Pain After Open Heart Surgery · recruiting
- NCT07037485 — The Predictive Value of Doppler Based Renal Ultrasound and Urinary Oxygen Tension for Prediction of Acute Kidney Injury · recruiting
- NCT07042906 — Comparison of the Factors Affecting PSI and BIS Values in Monitoring Anesthetic Depth During Open-Heart Surgery · active not recruiting
- NCT06551714 — The Effect of Neurophysiological Facilitation Techniques on Health Parameters in Early Stages After Open Heart Surgery · NA · recruiting
Other Hernando Gomez trials
Trials by the same sponsor.
- NCT05900284 — Safety and Feasibility of Metformin for Sepsis Induced AKI · Phase 2 · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06828432 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hernando Gomez
- Last refreshed: 6 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06828432.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing